Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-039028

Options or other derivatives

  • President and CEO acquired 134,584 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mack David Henry President and CEO 2021-05-12 Grant or award · Employee Stock Option (right to buy) +134,584 134,584 D
Loading xslF345X03/doc4.xml…